Fractyl Health, Inc. (GUTS) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Fractyl Health reported revenue of $0, down 100.0% from $93,000 the year before. Net income was -$141.0M, or -$22.32 per diluted share. Operating activities generated -$90.3M of cash, leaving -$90.9M of free cash flow. At fiscal year end, Fractyl Health held $121.4M in total assets against $111.9M in total liabilities, including $81.5M of cash and equivalents.
Open the full interactive Fractyl Health financials → Quarterly statements, key ratios, valuation history and price charts.
Fractyl Health Key Stats
| Share Price | $4.03 |
|---|---|
| Market Cap | $53.2M |
| Revenue YoY Growth | -100.0% |
| 52-Week Range | $4.03 – $28.44 |
| Shares Outstanding | 13.2 million (basic, 2026 Q2) |
Fractyl Health Income Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Revenue | $93,000 | $0 |
| Gross Profit | $43,000 | $0 |
| Operating Income | -$93.5M | -$96.8M |
| Pre-Tax Income | -$68.7M | -$141.0M |
| Income Tax | $0 | $0 |
| Net Income | -$68.7M | -$141.0M |
| Diluted EPS | -$19.44 | -$22.32 |
Fractyl Health Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | — | — | $0 | $0 |
| Net Income | -$45.6M | -$43.7M | $9.2M | -$25.5M |
| Diluted EPS | -$8.52 | -$0.58 | $0.72 | -$1.92 |
Fractyl Health Balance Sheet
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash & Equivalents | $67.5M | $81.5M |
| Current Assets | $71.8M | $87.6M |
| Total Assets | $108.1M | $121.4M |
| Current Liabilities | $19.8M | $18.3M |
| Total Long-Term Debt | $30.2M | $30.6M |
| Total Liabilities | $79.7M | $111.9M |
| Shareholders' Equity | $28.4M | $9.5M |
Fractyl Health Cash Flow Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash From Operations | -$65.5M | -$90.3M |
| Cash From Investing | -$1.8M | -$557,000 |
| Cash From Financing | $101.2M | $105.0M |
| Free Cash Flow | -$67.3M | -$90.9M |
Figures from Fractyl Health's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Fractyl Health financials page for every line item.
Fractyl Health Company Profile
| Ticker | GUTS |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Burlington, Massachusetts |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001572616 |
Frequently Asked Questions
What was Fractyl Health's revenue in fiscal 2025?
Fractyl Health (GUTS) reported revenue of $0 for fiscal 2025.
What was Fractyl Health's net income in fiscal 2025?
Fractyl Health reported net income of -$141.0M for fiscal 2025.
What was Fractyl Health's earnings per share (EPS) in fiscal 2025?
Fractyl Health's diluted EPS was -$22.32 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Fractyl Health generate in fiscal 2025?
Fractyl Health generated -$90.9M of free cash flow in fiscal 2025.
What was Fractyl Health's revenue last quarter?
In its most recent reported quarter (2026 Q2), Fractyl Health reported revenue of $0.
How much debt does Fractyl Health have?
Fractyl Health reported $30.6M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Fractyl Health are outstanding?
Fractyl Health reported a weighted average of 13.2 million basic shares outstanding in 2026 Q2.
What is Fractyl Health's market cap?
Based on its latest closing price, Fractyl Health (GUTS) has a market capitalization of about $53.2M.
When does Fractyl Health's fiscal year end?
Fractyl Health's fiscal year end, as registered with the SEC, is December 31.
Where is Fractyl Health headquartered?
Fractyl Health lists its business address in Burlington, Massachusetts in its SEC filings.